🇮🇹 Rimegepant 75mg daily dosing in Italy

Rimegepant 75mg daily dosing (rimegepant-75mg-daily-dosing) regulatory status in Italy.

Marketing authorisation

AIFA

  • Status: approved

Rimegepant 75mg daily dosing in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Italy

Frequently asked questions

Is Rimegepant 75mg daily dosing approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Rimegepant 75mg daily dosing in Italy?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.